All news articles for February 2021

© GettyImages/Tanaonte

Guest Article

What does Brexit mean for biopharma companies?

By Mike Pears and Joel Beevers, Patent Attorneys at Potter Clarkson

January 1, 2021 marked the UK’s official separation from the EU and with that has come a raft of changes to how the nation will now do business with the rest of the world.

Pic:getty/bankrx

J&J submits EUA application for single-shot COVID-19 vaccine

By Rachel Arthur

J&J pledges to start shipping doses of its COVID-19 vaccine in the US as soon as Emergency Use Authorization (EUA) is received from the Food and Drug Administration, while it plans to apply for Conditional Marketing Authorization in the EU in the...

Pic:getty/plyushkin

Novavax starts rolling reviews for COVID-19 vaccine

By Rachel Arthur

Novavax has started sharing early clinical data for its COVID-19 vaccine with health authorities in the UK, EU, US and Canada as it starts the rolling review process in these jurisdictions.

GettyImages/Chaz Bharj

South Africa suspends use of AstraZeneca jab in national rollout

By Jane Byrne

South Africa is halting the use of the Oxford University-AstraZeneca COVID-19 vaccine in its vaccination campaign following the release of trial data showing the jab offered limited protection against mild to moderate infection caused by the country’s...

Follow us

Products

View more

Webinars